AURA - CIK 0001501796
Aura Biosciences, Inc. (AURA) reported net income of -$106.19M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$106.19M | -22.2% |
| FY 2024 | -$86.92M | -13.8% |
| FY 2023 | -$76.41M | -30.0% |
| FY 2022 | -$58.76M | -66.7% |
| FY 2021 | -$35.25M | -58.7% |
| FY 2020 | -$22.21M | - |
Aura Biosciences, Inc. (AURA) reported net income of -$106.19M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2020 and fiscal 2025, Aura Biosciences, Inc.'s net income declined from -$22.21M to -$106.19M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.